A retrospective study assessing correlation of VEGFR2 cytoplasmic expression and survival rates in patients with metastatic breast cancer treated with Bevacizumab
Latest Information Update: 07 Jun 2017
At a glance
- Drugs Bevacizumab (Primary) ; Paclitaxel
- Indications Advanced breast cancer
- Focus Therapeutic Use
- 06 Jun 2017 Results presented at the 53rd Annual Meeting of the American Society of Clinical Oncology
- 02 Jun 2017 New trial record